EUVIMEDEUVIMED entdecken
Crossref

Rethinking informed consent in phage therapy: why location and approach matter

Ran Nir-Paz, Jean-Paul Pirnay, Tristan Ferry, Zuzanna Drulis-Kawa, Annika Y Classen, Antonia I Scobie, Rebecca Lester, Eyal Katvan, Sylvia Hafkemeyer, Shawna McCallin, Gina A Suh

Clinical Microbiology and Infection · 2026-08 · 32 (8) · 1211-1215

DOI: 10.1016/j.cmi.2026.04.007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Microbiology and Infection, 2026-08. Verfasst von Ran Nir-Paz und 10 weiteren Autor:innen. Beteiligte Einrichtung: ESGNTA - ESCMID Study Group for Non-Traditional Antibacterials, Basel, Switzerland; Department of Clinical Microbiology and Infectious Diseases, Hada…. Die Arbeit nennt 13 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Compassionate useHelsinki declarationInformed consentMagistral phagePersonalized therapyPhage therapy

Autor:innen und Institutionen

  • ESGNTA - ESCMID Study Group for Non-Traditional Antibacterials, Basel, Switzerland; Department of Clinical Microbiology and Infectious Diseases, Hadassah-Hebrew University Medical Center, Jerusalem, Israel; Faculty of M…
  • ESGNTA - ESCMID Study Group for Non-Traditional Antibacterials, Basel, Switzerland; Laboratory for Molecular and Cellular Technology, Queen Astrid Military Hospital, Brussels, Belgium.
  • ESGNTA - ESCMID Study Group for Non-Traditional Antibacterials, Basel, Switzerland; Infectious Diseases, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, Lyon, France; Centre interrégional de référence pour la prise…
  • ESGNTA - ESCMID Study Group for Non-Traditional Antibacterials, Basel, Switzerland; Department of Pathogen Biology and Immunology, University of Wroclaw, Wroclaw, Poland.
  • ESGNTA - ESCMID Study Group for Non-Traditional Antibacterials, Basel, Switzerland; Department I for Internal Medicine, Faculty of Medicine and University Hospital of Cologne, Cologne, Germany.
  • ESGNTA - ESCMID Study Group for Non-Traditional Antibacterials, Basel, Switzerland; Department of Infection, Royal Free London NHS Foundation Trust, UK; Bone Infection Unit, Royal National Orthopaedic Hospital NHS Trust…

Zitieren

APA

Nir-Paz, R., Pirnay, J. P., Ferry, T., Drulis-Kawa, Z., Classen, A. Y., Scobie, A. I., Lester, R., Katvan, E., Hafkemeyer, S., McCallin, S., & Suh, G. A. (2026). Rethinking informed consent in phage therapy: why location and approach matter. Clinical Microbiology and Infection, 32(8), 1211-1215. https://doi.org/10.1016/j.cmi.2026.04.007

Vancouver

Nir-Paz R, Pirnay JP, Ferry T, Drulis-Kawa Z, Classen AY, Scobie AI, et al. Rethinking informed consent in phage therapy: why location and approach matter. Clinical Microbiology and Infection. 2026;32(8):1211-1215. doi:10.1016/j.cmi.2026.04.007

BibTeX
@article{NirPaz2026,
  author = {Nir-Paz, Ran and Pirnay, Jean-Paul and Ferry, Tristan and Drulis-Kawa, Zuzanna and Classen, Annika Y and Scobie, Antonia I and Lester, Rebecca and Katvan, Eyal and Hafkemeyer, Sylvia and McCallin, Shawna and Suh, Gina A},
  title = {Rethinking informed consent in phage therapy: why location and approach matter},
  journal = {Clinical Microbiology and Infection},
  year = {2026},
  volume = {32},
  number = {8},
  pages = {1211--1215},
  doi = {10.1016/j.cmi.2026.04.007}
}
Kostenlos starten →